Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $6.07 Million - $10 Million
60,000 New
60,000 $7.13 Million
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $609,076 - $918,268
-5,200 Reduced 78.79%
1,400 $209,000
Q1 2022

May 18, 2022

BUY
$126.46 - $235.05 $404,672 - $752,160
3,200 Added 94.12%
6,600 $1.17 Million
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $767,788 - $1.25 Million
3,400 New
3,400 $858,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.2B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.